# Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option

> **NCT04926584** · — · RECRUITING · sponsor: **Klinikum Esslingen** · enrollment: 50 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** induction therapy

## Key facts

- **NCT ID:** NCT04926584
- **Lead sponsor:** Klinikum Esslingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-12-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04926584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04926584, "Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04926584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*